Many banks, but particularly the large banks like Citigroup (NYSE:C), have found the quality of their recent earnings reports challenged by those who do not approve of the large loan loss reserve releases that have buoyed the reported numbers. Does that change now, though, since conservatively-run U.S. Bancorp (NYSE:USB) has joined the list of banks recognizing reserve releases? While USB's reserve release was quite modest and the company's credit quality stands out as quite good, it may ultimately be a sign that conditions really are getting better for the banks.

IN PICTURES: 9 Simple Investing Ratios You Need To Know

The Quarter That Was
It is easy to get bogged down in the details of bank earnings releases, so here are some of the most significant take-away points.

USB saw revenue increase 1% on a sequential basis and 3% on an annual basis for the fourth quarter. Net interest income was up 1% and 6%, respectively for those time periods, while non-interest income was up 5% and 10%. Non-interest income has long been a very significant part of U.S. Bancorp's business (and a reason that the company fared better during the recession), but investors should realize that the numbers this quarter were inflated by some "other" items that may not be repeatable. Netting out all of the "other," this item would have been down 3% sequentially and up 9% annually.

USB saw its net interest margin fall slightly, but 3.83% is still a very good result. Average earning assets were up 3%, and the company increased its loan book by 2% (or 1% net of acquisitions). Although a higher net interest margin would be much better, this is what bank investors should want to see - loan growth, net interest income growth, and so on.

Credit quality continued to improve in the fourth quarter. The company recognized a small reserve release ($25 million, or about one cent of EPS), and non-performing asset and charge-off ratios all improved (and are at good levels on a relative basis). Investors should also note that U.S. Bancorp has reserves well in excess of current non-performing loans (162%) - that is very conservative relative to other banks like Comerica (NYSE:CMA) or the also extremely well-run M&T Bank (NYSE:MTB).

The Road Ahead
Relative to many other banks, U.S. Bancorp is in good shape. While the bank's size limits what it can do in terms of domestic acquisitions, and the company's conservative policies may preclude overseas expansion, the company is nevertheless at least in good position to resume lending and build its market share organically. A strong capital and credit position also leaves the company in good shape to boost its dividend payout, and that appears to be a priority for the bank. (For more, see 2010: A Year Of Banking Dangerously.)

Longer term, U.S. Bancorp does have some challenges when it comes to growth. Bank of Montreal (NYSE:BMO) is knocking on the door in some of USB's markets, and other competitors are likely to enter the U.S. as well. What's more, smaller banks like TCF Financial (NYSE:TCB), City National (NYSE:CYN) and PNC (NYSE:PNC) have options that USB does not in terms of M&A activities (as well as smaller bases from which to grow).

U.S. Bancorp also has to navigate the challenges offered up by the new regulatory environment. USB has long relied on various fees and non-interest revenues for a sizable chunk of its profits, and the Feds are crimping that business to some extent. By the same token, do not underestimate management - history says they will find new sources of fees and new profitable business ventures that fit into their risk preferences.

The Bottom Line
So, what is U.S. Bancorp worth? That question really centers around the sort of return on equity the company can get in the future. Assuming a long-term ROE of 15%, the shares look to be worth about $29 per share. If the company can match its 5-year average ROE of about 17.5%, that target moves to $35, and if investors believe the bank can recapture prior high ROE levels around 20%, the target jumps to over $41.

It seems as though it will be difficult for USB to get back to ROEs in the 20's or even the very high teens, but with even modest ROE recovery assumptions leading to attractive price targets, investors looking to build some exposure to financials should give very serious consideration to U.S. Bancorp shares. (For related reading, see Citi: More, Better, Faster, Please.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Investing

    How to Ballast a Portfolio with Bonds

    If January and early February performance is any guide, there’s a new normal in financial markets today: Heightened volatility.
  2. Stock Analysis

    Performance Review: Emerging Markets Equities in 2015

    Find out why emerging markets struggled in 2015 and why a half-decade long trend of poor returns is proving optimistic growth investors wrong.
  3. Investing

    Don't Freak Out Over Black Swans; Be Prepared

    Could 2016 be a big year for black swans? Who knows? Here's what black swans are, how they can devastate the unprepared, and how the prepared can emerge unscathed.
  4. Investing News

    Today's Sell-off: Are We in a Margin Liquidation?

    If we're in market liquidation, is it good news or bad news? That party depends on your timeframe.
  5. Investing News

    Bank Stocks: Time to Buy or Avoid? (WFC, JPM, C)

    Bank stocks have been pounded. Is this the right time to buy or should they be avoided?
  6. Stock Analysis

    Why the Bullish Are Turning Bearish

    Banks are reducing their targets for the S&P 500 for 2016. Here's why.
  7. Stock Analysis

    How to Find Quality Stocks Amid the Wreckage

    Finding companies with good earnings and hitting on all cylinders in this environment, although possible, is not easy.
  8. Stock Analysis

    Analyzing Sirius XM's Return on Equity (ROE) (SIRI)

    Learn more about the Sirius XM's overall 2015 performance, return on equity performance and future predictions for the company's ROE in 2016 and beyond.
  9. Budgeting

    5 Alternatives to Traditional Health Insurance

    Discover five of the most popular alternatives to traditional health insurance plans, alternatives that are increasingly popular as health insurance costs rise.
  10. Stock Analysis

    Will Virtusa Corporation's Stock Keep Chugging in 2016? (VRTU)

    Read a thorough review and analysis of Virtusa Corporation's stock looking to project how well the stock is likely to perform for investors in 2016.
  1. When does a growth stock turn into a value opportunity?

    A growth stock turns into a value opportunity when it trades at a reasonable multiple of the company's earnings per share ... Read Full Answer >>
  2. What is the formula for calculating EBITDA?

    When analyzing financial fitness, corporate accountants and investors alike closely examine a company's financial statements ... Read Full Answer >>
  3. How do I calculate the P/E ratio of a company?

    The price-earnings ratio (P/E ratio) is a valuation measure that compares the level of stock prices to the level of corporate ... Read Full Answer >>
  4. How do you calculate return on equity (ROE)?

    Return on equity (ROE) is a ratio that provides investors insight into how efficiently a company (or more specifically, its ... Read Full Answer >>
  5. How do you calculate working capital?

    Working capital represents the difference between a firm’s current assets and current liabilities. The challenge can be determining ... Read Full Answer >>
  6. What is the formula for calculating the current ratio?

    The current ratio is a financial ratio that investors and analysts use to examine the liquidity of a company and its ability ... Read Full Answer >>
Trading Center